✦ LIBER ✦

Serum tetranectin and CA-125 used to monitor the course of treatment in ovarian cancer patients

✍ Scribed by Claus K. Høgdall; Ulla Hørding; Bent Nørgaard-Pedersen; Kim Toftager-Larsen; Inge Clemmensen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive values of serum tetranectin a

✍ C. Høgdall; E. Høgdall; J. Blaakaer; L. Christensen; E. Glud; J. Vuust; B. Nøgaa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Use of CA 125 monoclonal antibody to mon

✍ S Kudlacek; K Schieder; H Kolbl; W Neunteufel; C Nowotny; G Breitenecker; G Bieg 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Use of CA 125 monoclonal antibody to mon

✍ S Kudlacek; K Schieder; H Kolbl; W Neunteufel; C Nowotny; G Breitenecker; G Bieg 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 138 KB

The Prognostic Value of Pretherapeutic T

✍ Xiaohong Deng; Estrid V.S. Høgdall; Claus K. Høgdall; Bent Nørgaard-Pedersen; Mo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Evaluation of serum CA 125 levels in the

✍ I.B. Vergote; O.P. Bormer; V.M. Abeler 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 139 KB

Evaluation of serum CA 125 levels in the

✍ Vergote, Ignace B.; Børmer, Ole P.; Abeler, Vera M. 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 581 KB